Would You Consider Undergoing Online Ketamine-Assisted Psychotherapy?

October 12, 2020 13:39:21

The COVID-19 pandemic has brought with it immense challenges for all sections of society, including the nascent field of psychedelic-assisted psychotherapy. In the new norm of social distancing and the constant threat that stay-at-home orders will be reissued in places where they have been eased, it is necessary to consider new approaches of doing things. Virtual ketamine-assisted psychotherapy (“KAP”) sessions are one of the new developments to consider if you are a patient who now finds yourself unable to visit the ketamine clinic you used to frequent for sessions before the pandemic struck. Here are some of the reasons that make online ketamine-assisted psychotherapy desirable.

Online KAP is More Affordable

The standard or in-clinic KAP sessions demand anywhere from 10-20 hours per session. This time goes to the intake with a therapist, time spent with a physician, the hours spent preparing, the time that goes to experiential sessions and the time allocated to psychedelic integration therapy after the sessions. Patients therefore have to fork out a large sum of money for the treatment, and since insurance companies don’t cover KAP, this cost is met out of pocket.

Online KAP significantly cuts this cost since the treatment process is conducted virtually. The reduced cost means more patients can now afford to enroll for the treatment that they previously regarded as prohibitively priced.

Online KAP is Highly Accessible

Licensed KAP clinics are still very few and far between, and this means that only a tiny fraction of the patients who need the services offered can access a physical location.

However, virtual ketamine-assisted psychotherapy breaks the barriers of geographical location and open up treatment to people from all locations. Given that most potential beneficiaries are individuals with forms of depression that are unresponsive to existing pharmaceuticals, KAP allows these individuals with little drive or motivation to undergo treatment from the comfort of their homes.

The Home Setting Offers Convenience and Comfort

Many people who suffer from mental illnesses get anxious when they are away from their homes. Conducting treatment sessions online therefore allows these individuals to remain within the place that they consider safe.

Additionally, KAP sessions often require patients to remain at the clinic for a while in order to give side effects, such as nausea, a chance to abate. Rather than stay at a clinic as you wait to recover from the session’s effects, you can simply lie in your own bed at home or enjoy your couch if the session is conducted virtually.

It isn’t all fairies and roses however on the subject of virtual KAP. A lot of planning has to go into the process in order to mitigate all the potential risks and pitfalls of not working within a highly controlled clinical setting. For example, communication must be stepped up, especially by the therapist, in order to ensure that proper set and setting are created prior to KAP sessions. KAP professionals also have to be extremely careful while conducting virtual assessments of their patients before writing ketamine lozenge prescriptions. It is therefore no wonder that entities like Cybin Corp. insist that only licensed professionals should administer psychedelics like ketamine in order to limit their abuse or the possibility of adverse events.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.